News
NEW YORK – QuidelOrtho announced Monday an integration deal making fecal biomarker testing from Bühlmann Laboratories available on QuidelOrtho's Vitros system. The Bühlmann fecal tests detect ...
The company's next-generation sequencing-based test is used to aid the detection of cancers in patients with indeterminate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback